vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $295.9M, roughly 1.7× Eastern Bankshares, Inc.). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs 6.8%, a 15.2% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs -1.7%). Over the past eight quarters, Eastern Bankshares, Inc.'s revenue compounded faster (38.6% CAGR vs -0.1%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
EBC vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $493.8M |
| Net Profit | $65.3M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 22.1% | 6.8% |
| Revenue YoY | 710.6% | -1.7% |
| Net Profit YoY | -34.4% | 10.5% |
| EPS (diluted) | $0.29 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | $493.8M | ||
| Q3 25 | $241.5M | $492.9M | ||
| Q2 25 | $244.9M | $468.8M | ||
| Q1 25 | $31.1M | $458.4M | ||
| Q4 24 | $216.5M | $502.4M | ||
| Q3 24 | $203.4M | $511.2M | ||
| Q2 24 | $154.0M | $504.3M |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | $33.7M | ||
| Q3 25 | $106.1M | $71.7M | ||
| Q2 25 | $100.2M | $39.3M | ||
| Q1 25 | $-217.7M | $20.7M | ||
| Q4 24 | $60.8M | $30.5M | ||
| Q3 24 | $-6.2M | $19.4M | ||
| Q2 24 | $26.3M | $-153.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.9% | ||
| Q3 25 | 38.9% | 13.8% | ||
| Q2 25 | 41.0% | 12.8% | ||
| Q1 25 | -590.9% | 7.0% | ||
| Q4 24 | 33.3% | 7.8% | ||
| Q3 24 | -1.6% | 6.6% | ||
| Q2 24 | 24.7% | -31.3% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | 6.8% | ||
| Q3 25 | 44.0% | 14.5% | ||
| Q2 25 | 40.9% | 8.4% | ||
| Q1 25 | -699.2% | 4.5% | ||
| Q4 24 | 28.1% | 6.1% | ||
| Q3 24 | -3.0% | 3.8% | ||
| Q2 24 | 17.1% | -30.3% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | $0.40 | ||
| Q3 25 | $0.53 | $0.84 | ||
| Q2 25 | $0.50 | $0.46 | ||
| Q1 25 | $-1.08 | $0.24 | ||
| Q4 24 | $0.29 | $0.37 | ||
| Q3 24 | $-0.03 | $0.23 | ||
| Q2 24 | $0.16 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $4.3B | $865.9M |
| Total Assets | $30.6B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | $375.2M | ||
| Q3 25 | $703.4M | $340.1M | ||
| Q2 25 | $948.3M | $224.7M | ||
| Q1 25 | $609.0M | $99.0M | ||
| Q4 24 | $1.9B | $229.9M | ||
| Q3 24 | $1.7B | $103.8M | ||
| Q2 24 | $1.4B | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $865.9M | ||
| Q3 25 | $3.8B | $890.7M | ||
| Q2 25 | $3.7B | $833.8M | ||
| Q1 25 | $3.6B | $789.2M | ||
| Q4 24 | $3.6B | $764.9M | ||
| Q3 24 | $3.7B | $732.5M | ||
| Q2 24 | $3.0B | $706.5M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | $2.2B | ||
| Q3 25 | $25.5B | $2.2B | ||
| Q2 25 | $25.5B | $2.1B | ||
| Q1 25 | $25.0B | $2.0B | ||
| Q4 24 | $25.6B | $2.2B | ||
| Q3 24 | $25.5B | $2.1B | ||
| Q2 24 | $21.0B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | $114.1M | ||
| Q3 25 | $157.1M | $137.3M | ||
| Q2 25 | $123.9M | $137.2M | ||
| Q1 25 | $47.3M | $-117.5M | ||
| Q4 24 | $283.8M | $133.0M | ||
| Q3 24 | $108.3M | $91.8M | ||
| Q2 24 | $54.3M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | 3.39× | ||
| Q3 25 | 1.48× | 1.91× | ||
| Q2 25 | 1.24× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | 4.67× | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | 2.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EBC
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
